この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2001/10/171 分で読めます
Determination of Regulatory Review Period for Purposes of Patent Extension; Synercid; Correction
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 21, 2001 (66 FR 486920). The document determined the regulatory review period for Synercid and published the notice of that determination as required by law. The document published with an inadvertent error. This document corrects that error.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →